Mayo Clinic - Mayo Clinic: First In-human Trial of Endoxifen Shows Promise as Breast Cancer...

A Phase I trial of endoxifen, an active metabolite of the cancer drug tamoxifen, indicates http://t.co/5O166JaLJM

via VAT ENGPlus Combo | VATPlus | MotionTrak http://t.co/5O166JaLJM